Lucid Diagnostics (LUCD) Receivables (2021 - 2026)
Lucid Diagnostics (LUCD) reported Receivables of $689000.0 for Q1 2026, up 1029.51% on a YoY basis from $61000.0 in Q1 2025, and up 7.15% quarter-over-quarter from $643000.0 in Q4 2025.
Lucid Diagnostics (LUCD) Receivables (2021 - 2026) Analysis & Trends
Lucid Diagnostics has reported Receivables for 6 years, with the latest figure at $689000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables rose 1029.51% year-over-year to $689000.0; the trailing twelve-month figure through Mar 2026 stood at $689000.0 (up 1029.51% YoY), and the FY2025 full-year result was $643000.0, up 1328.89% from the prior year.
- Receivables for Q1 2026 stood at $689000.0, up from $643000.0 in the prior quarter.
- The five-year high for Receivables was $10.7 million in Q2 2023, with the low at $21000.0 in Q3 2023.
- Historically, Receivables has averaged $2.2 million across 5 years, with a median of $461500.0 in 2025.
- Annual changes were most pronounced in 2022 — Receivables surged 3220.5% — and 2023, when it tumbled 99.68%.
- Lucid Diagnostics' Receivables stood at $5.0 million in 2022, then tumbled by 99.1% to $45000.0 in 2023, then changed by 0.0% to $45000.0 in 2024, then jumped by 1328.89% to $643000.0 in 2025, then grew by 7.15% to $689000.0 in 2026.
- The last three Receivables figures came in at $689000.0 (Q1 2026), $643000.0 (Q4 2025), and $550000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.09 Bn |
| 10 | Lucid Diagnostics | 149.20 Mn | 121.33 Mn | -325,000.00 | 689,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 689,000.00 |
| Dec 31, 2025 | 643,000.00 |
| Sep 30, 2025 | 550,000.00 |
| Jun 30, 2025 | 373,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 10.73 Mn |
| Mar 31, 2023 | 7.65 Mn |
| Dec 31, 2022 | 4.98 Mn |
| Sep 30, 2022 | 6.64 Mn |
| Mar 31, 2022 | 1.86 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 200,000.00 |